how big is Nath Bio-Genes?

Jun 06 2025 06:14 PM IST
share
Share Via
As of March 2024, Nath Bio-Genes (India) Ltd has a market capitalization of 368.11 Cr, with net sales of 364.91 Cr and a net profit of 38.59 Cr over the latest four quarters. Shareholder's funds are valued at 609.92 Cr, and total assets amount to 880.23 Cr.
Market Cap: Nath Bio-Genes (India) Ltd has a market capitalization of 368.11 Cr, categorizing it as a Micro Cap company.

Recent Quarterly Performance: The company reported a sum of Net Sales of 364.91 Cr and a sum of Net Profit of 38.59 Cr for the latest 4 quarters, which is Consolidated data.

Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending March 2024. Shareholder's Funds are valued at 609.92 Cr, and Total Assets amount to 880.23 Cr.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read